Print this article

Corden Pharma – Oligonucleotides: Promising Therapeutics with Significant Challenges


e-version image

Click HERE to download the PDF version


Matthieu Giraud Ph.D1, CHRISTIAN AHLMARK2

1. Director, Global Peptides, Oligonucleotides, Lipids & Carbohydrates Platform CordenPharma International

2. Associate Director, Sales & Key Account Management CordenPharma International

In recent years, interest in oligonucleotide therapeutics has resurged, as new approaches, clinical